omniture
logo
Search
SK bioscience
Media Room

Photo News

rss
SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions

SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions

2026-07-02 20:00 3752
SK bioscience Joins Forces with Global Institutions to Advance Rotavirus Vaccine Development

SK bioscience Joins Forces with Global Institutions to Advance Rotavirus Vaccine Development

2026-06-09 20:00 3452
SK bioscience Secures First UNICEF Procurement Contract Improving Vaccine Access

SK bioscience Secures First UNICEF Procurement Contract Improving Vaccine Access

2026-06-02 20:00 4627
SK bioscience Board Approves Financing Plan Supported by Korea Growth Fund

SK bioscience Board Approves Financing Plan Supported by Korea Growth Fund

2026-05-29 20:00 4610
SK bioscience Signs Vaccine Technology Transfer Agreement with Colombia's VECOL to Advance Local Vaccine Manufacturing in Latin America

SK bioscience Signs Vaccine Technology Transfer Agreement with Colombia's VECOL to Advance Local Vaccine Manufacturing in Latin America

2026-05-26 20:00 9036
SK bioscience Secures Funding to Advance RSV Preventive Antibody Development with RIGHT Foundation Support

SK bioscience Secures Funding to Advance RSV Preventive Antibody Development with RIGHT Foundation Support

2026-03-18 20:00 7306
SK bioscience Initiates International Phase 1/2 Clinical Trial of Universal Vaccine Candidate Targeting Sarbecovirus Family

SK bioscience Initiates International Phase 1/2 Clinical Trial of Universal Vaccine Candidate Targeting Sarbecovirus Family

2026-01-29 10:10 7882
SK bioscience, MSD, and Hilleman Laboratories Advance Zaire ebolavirus Vaccine Development with CEPI Funding

SK bioscience, MSD, and Hilleman Laboratories Advance Zaire ebolavirus Vaccine Development with CEPI Funding

2026-01-22 21:00 8283
IDT Biologika Accelerates Global CDMO Expansion Manufacturing capabilities highlighted through consecutive participation in WVC, CPHI and BIO-Europe 2025

IDT Biologika Accelerates Global CDMO Expansion Manufacturing capabilities highlighted through consecutive participation in WVC, CPHI and BIO-Europe 2025

2025-11-05 21:00 3742
SK bioscience Files for First-in-Human Trial of Universal Coronavirus Vaccine (Pan-sarbecovirus Vaccine) GBP511 Phase 1/2 study in Australia

SK bioscience Files for First-in-Human Trial of Universal Coronavirus Vaccine (Pan-sarbecovirus Vaccine) GBP511 Phase 1/2 study in Australia

2025-10-15 20:00 4193
SK bioscience Submits IND for Phase 3 Trial of 2-Dose Varicella Vaccine Reflecting Global Standard Shift

SK bioscience Submits IND for Phase 3 Trial of 2-Dose Varicella Vaccine Reflecting Global Standard Shift

2025-09-02 19:00 3848
SK bioscience Discusses Further Collaboration with the Gates Foundation to Advance Global Health

SK bioscience Discusses Further Collaboration with the Gates Foundation to Advance Global Health

2025-08-21 20:00 3246
SK bioscience Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine

SK bioscience Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine

2025-05-21 20:00 3606
SK bioscience Joins Korea's National Initiative to Develop Avian Influenza Vaccine Amid Rising Pandemic Threats

SK bioscience Joins Korea's National Initiative to Develop Avian Influenza Vaccine Amid Rising Pandemic Threats

2025-05-06 20:00 3417
SK bioscience Initiates Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate

SK bioscience Initiates Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate

2025-02-25 21:00 4017
SK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate

SK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate

2024-12-12 21:00 3914
SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia

SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia

2024-10-23 20:00 3976
SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia

SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia

2024-10-23 15:11 3599
Korea's SK bioscience Acquires Stake in U.S. Biotech Fina Biosolutions

Korea's SK bioscience Acquires Stake in U.S. Biotech Fina Biosolutions

2024-10-08 20:00 3073
South Korea's SK bioscience Completes Acquisition of Germany's CDMO IDT Biologika

South Korea's SK bioscience Completes Acquisition of Germany's CDMO IDT Biologika

2024-10-02 20:00 4224
SK bioscience Exports Influenza Vaccine to Thailand, Entering Southern Hemisphere Market

SK bioscience Exports Influenza Vaccine to Thailand, Entering Southern Hemisphere Market

2024-03-21 13:24 4499
12